These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Wessale JL; Adler AL; Novosad EI; Calzadilla SV; Dayton BD; Marsh KC; Winn M; Jae HS; von Geldern TW; Opgenorth TJ; Wu-Wong JR Clin Sci (Lond); 2002 Aug; 103 Suppl 48():112S-117S. PubMed ID: 12193067 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Clozel M; Breu V; Burri K; Cassal JM; Fischli W; Gray GA; Hirth G; Löffler BM; Müller M; Neidhart W Nature; 1993 Oct; 365(6448):759-61. PubMed ID: 8413655 [TBL] [Abstract][Full Text] [Related]
6. [Endothelins and their non-vascular effects]. Lotersztajn S Pathol Biol (Paris); 1993 Feb; 41(2):143-8. PubMed ID: 8392159 [No Abstract] [Full Text] [Related]
9. Endothelin receptor antagonists and cerebral vasospasm. Zimmermann M; Seifert V Clin Auton Res; 2004 Jun; 14(3):143-5. PubMed ID: 15241641 [No Abstract] [Full Text] [Related]
10. [Endothelin receptor antagonists in pulmonary arterial hypertension]. Tokgöz HC; Can MM; Kaymaz C Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750 [TBL] [Abstract][Full Text] [Related]
11. Characterization of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications. Warner TD Eur Heart J; 1993 Nov; 14 Suppl I():42-7. PubMed ID: 8293780 [TBL] [Abstract][Full Text] [Related]
12. The endothelin system. A new target for therapeutic intervention. Yanagisawa M Circulation; 1994 Mar; 89(3):1320-2. PubMed ID: 8124823 [No Abstract] [Full Text] [Related]
13. [Effects, side effects and interactions. Endothelin and endothelin receptor antagonists]. Dahse AJ; Nieber K Pharm Unserer Zeit; 2010 Nov; 39(6):436-41. PubMed ID: 20967931 [No Abstract] [Full Text] [Related]
14. Endothelin receptor antagonists as antihypertensives: the next frontier. Epstein BJ; Anderson S Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):675-87. PubMed ID: 19505283 [TBL] [Abstract][Full Text] [Related]
15. Endothelin as a clinical target in the treatment of systemic hypertension. Prasad VS; Palaniswamy C; Frishman WH Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680 [TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists: status and learning 20 years on. Palmer MJ Prog Med Chem; 2009; 47():203-37. PubMed ID: 19328292 [No Abstract] [Full Text] [Related]